Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in the intensive care unit

Surgery

Volumn 124, Issue 1, 1998, Pages 65-72

  Jabs, C M ^a   Sigurdsson, G H ^a   Neglen, P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; HIGH ENERGY PHOSPHATE; HUMAN; INTENSIVE CARE UNIT; MALE; MUSCLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; SURVIVAL TIME;

EID: 0031902236     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(98)70076-5     Document Type: Article

References (19)

1. CM Jabs WJ Ferrell HJ Robb Plasma changes in endotoxin and anaphylactic shock (ATP, ADP and creatine phosphate) Ann Clin Lab Sci 9 1979 121 132
2. TE Bertorini V Shively B Taylor GMA Palmieri IH Fox ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase Neurology 35 1985 1355 1357
3. P Neglen CM Jabs B Eklof Plasma metabolic disturbances and reperfusion injury following partial limb ischemia in man Eur J Vasc Surg 3 1989 165 172
4. MH Weil A Affi Experimental and clinical studies in lactate and pyruvate as indicators of the severity of circulatory shock Circulation 41 1970 989 1001
5. CM Jabs P Neglen B Eklof Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock Eur J Surg 1961 1995 147 155
6. KY Liaw J Askanzi CB Michelson LR Kantrowitz P Furst P Kinney Effect of injury and sepsis on high energy phosphates in muscle and red cells J Trauma 20 1980 755 759
7. J Karlsson T Wellerson SJ Leshin CB Mullins JH Mithell Skeletal muscle metabolites in patients with cardiogenic shock and severe congestive heart failure Scand J Clin Lab Invest 35 1975 73 79
8. CM Grum RH Simon DR Danlzker IH Fox Evidence for adenosine triphosphate degradation in critically ill patients Chest 88 1985 763 768
9. WA Knaus EA Graper DP Wagner APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
10. CM Jabs WJ Ferrell HJ Robb Microdetermination of plasma ATP and creatine phosphate concentrations with a luminescence biometer Clin Chem 23 1977 2254 2257
11. CM Jabs WJ Ferrell HJ Robb Plasma ADP levels: direct determination with luciferase luminescencesing a biometer Clin Biochem 11 1978 190 192
12. CM Jabs P Neglen B Eklof Plasma creatine determination using a luminescence method Biochem Med Metab Biol 39 1988 267 272
13. CM Jabs P Neglen B Eklof EJ Thomas Adenosine, inosine and hypoxanthine/xanthine measured in tissue and plasma by a luminescence method Clin Chem 36 1990 81 87
14. I Gutman AE Wahlefeld L-(+)-lactate determination with lactate dehydrogenase and NAD HV Bergmeyer Methods of enzymatic analysis 1974 Verlag Chemie Intl Deerfield Beach (FL) 1464 1468
15. CJ Threlfall RA Maxwell HB Stoner Post-traumatic creatinuria J Trauma 24 1984 516 523
16. R Rubio RM Berne M Katore Release of adenosine in reactive hyperemia of the dog heart Am J Physiol 216 1969 55 62
17. G Kugler Myocardial release of inosine, hypoxanthine and lactate during pacing-induced angina in humans with coronary artery disease Eur J Cardiol 9 1979 227 240
18. RG Cutler Urate and ascorbate: their possible roles as antioxidants in determining longevity of mammalian species Arch Gerontol Geriatr 3 1984 321 348
19. V Vitek R Cowley Blood lactate in the prognosis of various forms of shock Ann Surg 173 1971 308 313